Agentic Drug Discovery Program by Loka
Loka · Intelligence & Research
Certification per AWS Marketplace.
Evidence tier Source Confirmed · 4 captures on record
What the publisher says
As described on AWS Marketplace.
Loka’s Agentic Drug Discovery program transforms pharmaceutical research by integrating cutting-edge AI models and databases into a collaborative, streamlined process.
Our engagement begins with a discovery and planning phase, customizing the AI solution to your specific needs. We then develop and integrate leading biological models like ESM, DiffDock, and BioNeMo, facilitating your ability to query both public and private databases through simple conversational interfaces.
Show the rest of the publisher’s description (12 more lines)
The final validation phase ensures the solution is robust, accurate, and ready for deployment, establishing a new benchmark for efficiency and precision in drug discovery.
**AWS Tools Used**
- Bedrock
- DynamoDB
- RDS
- Fargate
- Route52
- EC2
- ECR
- S3
- Secret Manager
- Amazon Cognito
Highlights
Highlighted by the publisher on AWS Marketplace.
Conversational & Customizable Access: Researchers can interact with advanced AI models through a simple chat interface, tailored to integrate seamlessly with internal data and workflows—no engineering required.
Flexible Model & Data Integration: Combine public models (e.g., ESM, DiffDock, BioNeMo) with proprietary models and datasets for a powerful, end-to-end drug discovery toolkit.
Automated Agentic Workflows: Streamline multi-step research processes—from hypothesis generation to execution—using AI agents that operate autonomously to accelerate discovery.
Agent build and provenance
See the full provenance
The layer-by-layer build, the evidence behind each claim, the risk basis and the cross-marketplace links are open to any account. Some rows are disclosed, some the source leaves Unknown; a free account shows you which.
Sources
Linked repositories
Unknown means this listing does not publish a repository. It is not a statement that the code is closed, and a linked repository is not a claim that the publisher wrote it: the registry computes that relationship privately and does not publish it.
Evidence risk is the share of the build you cannot see before you deploy, not a security rating. Sign in to see the layer-by-layer basis for this band.